These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3550377)

  • 1. The synthetic 32-46 fragment of human growth hormone increases insulin and glucagon levels in the conscious dog.
    Stevenson RW; Stebbing N; Rudman CG; Williams PE; Cherrington AD
    Metabolism; 1987 Apr; 36(4):400-4. PubMed ID: 3550377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthetic human growth hormone fragment (32-38) increases glucose uptake in the conscious dog.
    Stevenson RW; Stebbing N; Jones T; Carr K; Jones PM; Hii C; Cherrington AD
    Acta Endocrinol (Copenh); 1988 Apr; 117(4):457-62. PubMed ID: 3291525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of insulin on glucagon-stimulated glucose production in the conscious dog.
    Steiner KE; Williams PE; Lacy WW; Cherrington AD
    Metabolism; 1990 Dec; 39(12):1325-33. PubMed ID: 2246975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of somatostatin on epinephrine-stimulated glucose production in the dog.
    Stevenson RW; Steiner KE; Williams PE; Cherrington AD
    Metabolism; 1987 May; 36(5):451-7. PubMed ID: 2883556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog.
    McGuinness OP; Murrell S; Moran C; Bracy D; Cherrington AD
    Metabolism; 1994 Oct; 43(10):1310-7. PubMed ID: 7934986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an intrahepatic contribution to the waning effect of glucagon on glucose production in the conscious dog.
    Cherrington AD; Diamond MP; Green DR; Williams PE
    Diabetes; 1982 Oct; 31(10):917-22. PubMed ID: 6759225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man.
    MacGorman LR; Rizza RA; Gerich JE
    J Clin Endocrinol Metab; 1981 Sep; 53(3):556-9. PubMed ID: 6114964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of truncated glucagon-like peptide-1 on pancreatic hormone release in normal conscious dogs.
    Kawai K; Suzuki S; Ohashi S; Mukai H; Murayma Y; Yamashita K
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):661-7. PubMed ID: 2284891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs.
    Frizzell RT; Hendrick GK; Biggers DW; Lacy DB; Donahue DP; Green DR; Carr RK; Williams PE; Stevenson RW; Cherrington AD
    Diabetes; 1988 Jun; 37(6):749-59. PubMed ID: 3289995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Net hepatic lactate balance following mixed meal feeding in the four-day fasted conscious dog.
    Davis MA; Williams PE; Cherrington AD
    Metabolism; 1987 Sep; 36(9):856-62. PubMed ID: 3306279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation.
    Miller JD; Ganguli S; Sperling MA
    Diabetes; 1983 May; 32(5):439-44. PubMed ID: 6301913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations.
    Krentz AJ; Boyle PJ; Macdonald LM; Schade DS
    Metabolism; 1994 Jan; 43(1):24-31. PubMed ID: 8289671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects.
    Hoogwerf BJ; Bantle JP; Gaenslen HE; Greenberg BZ; Senske BJ; Francis R; Goetz FC
    Metabolism; 1986 Feb; 35(2):122-5. PubMed ID: 3511350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative hypothalamic glucoreceptors play no essential role in the response to moderate hypoglycemia.
    Cane P; Artal R; Bergman RN
    Diabetes; 1986 Mar; 35(3):268-77. PubMed ID: 3005093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast.
    Hendrick GK; Frizzell RT; Williams PE; Cherrington AD
    Am J Physiol; 1990 May; 258(5 Pt 1):E841-9. PubMed ID: 2185665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs.
    Cherrington AD; Fuchs H; Stevenson RW; Williams PE; Alberti KG; Steiner KE
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E137-44. PubMed ID: 6380303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered ability of the liver to produce glucose following a period of glucagon deficiency.
    Deri JJ; Williams PE; Steiner KE; Cherrington AD
    Diabetes; 1981 Jun; 30(6):490-5. PubMed ID: 6112181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
    Ader M; Agajanian T; Finegood DT; Bergman RN
    Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of morphine on glucose homeostasis in the conscious dog.
    Radosevich PM; Williams PE; Lacy DB; McRae JR; Steiner KE; Cherrington AD; Lacy WW; Abumrad NN
    J Clin Invest; 1984 Oct; 74(4):1473-80. PubMed ID: 6148357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin infusion increases plasma insulin and glucagon levels and glucose production and uptake in the normal dog.
    Altszuler N; Hampshire J
    Diabetes; 1981 Feb; 30(2):112-4. PubMed ID: 7009266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.